Targeting key autophagic signaling pathways, such as TNK2/ACK1-mediated phosphorylation of ATP5F1A, can hinder prostate cancer progression by promoting mitophagy and reducing tumor growth [29]. Here, ATP5F1A is linked to neoplasm.